1. Home
  2. FRSX vs SNOA Comparison

FRSX vs SNOA Comparison

Compare FRSX & SNOA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • FRSX
  • SNOA
  • Stock Information
  • Founded
  • FRSX N/A
  • SNOA 1999
  • Country
  • FRSX Israel
  • SNOA United States
  • Employees
  • FRSX N/A
  • SNOA N/A
  • Industry
  • FRSX Computer Software: Prepackaged Software
  • SNOA Biotechnology: Pharmaceutical Preparations
  • Sector
  • FRSX Technology
  • SNOA Health Care
  • Exchange
  • FRSX Nasdaq
  • SNOA Nasdaq
  • Market Cap
  • FRSX 8.2M
  • SNOA 7.5M
  • IPO Year
  • FRSX 2017
  • SNOA 2007
  • Fundamental
  • Price
  • FRSX $2.09
  • SNOA $4.43
  • Analyst Decision
  • FRSX
  • SNOA
  • Analyst Count
  • FRSX 0
  • SNOA 0
  • Target Price
  • FRSX N/A
  • SNOA N/A
  • AVG Volume (30 Days)
  • FRSX 75.7K
  • SNOA 109.7K
  • Earning Date
  • FRSX 09-21-2025
  • SNOA 11-06-2025
  • Dividend Yield
  • FRSX N/A
  • SNOA N/A
  • EPS Growth
  • FRSX N/A
  • SNOA N/A
  • EPS
  • FRSX N/A
  • SNOA N/A
  • Revenue
  • FRSX $452,000.00
  • SNOA $14,912,000.00
  • Revenue This Year
  • FRSX N/A
  • SNOA $23.00
  • Revenue Next Year
  • FRSX N/A
  • SNOA $24.59
  • P/E Ratio
  • FRSX N/A
  • SNOA N/A
  • Revenue Growth
  • FRSX N/A
  • SNOA 17.43
  • 52 Week Low
  • FRSX $1.98
  • SNOA $1.75
  • 52 Week High
  • FRSX $18.41
  • SNOA $6.92
  • Technical
  • Relative Strength Index (RSI)
  • FRSX 32.79
  • SNOA 51.27
  • Support Level
  • FRSX $2.30
  • SNOA $4.31
  • Resistance Level
  • FRSX $2.63
  • SNOA $4.68
  • Average True Range (ATR)
  • FRSX 0.21
  • SNOA 0.19
  • MACD
  • FRSX 0.01
  • SNOA -0.08
  • Stochastic Oscillator
  • FRSX 15.44
  • SNOA 21.43

About FRSX Foresight Autonomous Holdings Ltd.

Foresight Autonomous Holdings Ltd is a technology company engaged in the design, development and commercialization of vision systems for the automotive industry. The company develops both in-line-of-sight vision systems and beyond-line-of-sight cellular-based applications through its wholly-owned subsidiaries. Its systems are designed to improve driving safety by enabling accurate and reliable threat detection while ensuring the lowest rates of false alerts. Foresight is pursuing several markets and believes its modern systems will revolutionize automotive safety by providing an automotive-grade, cost-effective platform.

About SNOA Sonoma Pharmaceuticals Inc.

Sonoma Pharmaceuticals Inc is a specialty pharmaceutical company operating in the United States. It is engaged in identifying, developing, and commercializing differentiated therapies for patients living with chronic skin conditions. The company focuses on the development and commercialization of therapeutic solutions in medical dermatology to treat skin conditions, such as acne, atopic dermatitis, and scarring. The key products of the company are Celacyn, Ceramax Skin Barrier Cream, Mondoxyne, Alevicyn, SebuDerm, Microcyn, and Microcyn which are available for various skin treatments such as scars, itchy skin, minor skin irritations, rashes, and others. The company derives revenue from the sale of products in the United States, Latin America, Europe, Asia, and other countries.

Share on Social Networks: